Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper advertisement under Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sun Pharmaceutical Industries Ltd - 524715 - Clarification / Confirmation On News Item
Clarification / Confirmation on news item as per letter attached. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing on www.business-standard.com August 03, 2019, titled "Sun Pharma shuts two clinical units in Vadodara for cost efficiency".The reply is awaited. Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to the announcement of financial results for the first quarter ending June 30, 2019, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia Sun Pharma shuts two clinical pharmacology units in Vadodara
Drug major Sun Pharma on Saturday said it is discontinuing operations at two clinical pharmacology units in Vadodara (Gujarat) to bring in efficienci Sun Pharma shuts down two R&D; units in Vadodara; lays off some employees
Market sources peg the number at 85 personnel who have been terminated and given three months salary in advance Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Please find enclosed herewith our Revised Press Release relating to regulatory filing of Tildrakizumab in Japan, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to regulatory filing of Tildrakizumab in Japan, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, Dilip Shanghvi takes 99% pay cut despite Sun Pharma's 27% earnings growth
Shanghvi, one of the lowest-paid CEOs in India's pharmaceutical sector, drew a salary of Rs 1 during 2018-19